Tatjana Stankovic
Tatjana Stankovic
Professor of Cancer Genetics
Verified email at
Cited by
Cited by
The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder
GS Stewart, RS Maser, T Stankovic, DA Bressan, MI Kaplan, NGJ Jaspers, ...
Cell 99 (6), 577-587, 1999
The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage
GS Stewart, S Panier, K Townsend, AK Al-Hakim, NK Kolas, ES Miller, ...
Cell 136 (3), 420-434, 2009
ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer
T Stankovic, AMJ Kidd, A Sutcliffe, GM McGuire, P Robinson, P Weber, ...
The American Journal of Human Genetics 62 (2), 334-345, 1998
Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia
T Stankovic, P Weber, G Stewart, T Bedenham, J Murray, PJ Byrd, ...
The Lancet 353 (9146), 26-29, 1999
Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid …
O Goodyear, A Agathanggelou, I Novitzky-Basso, S Siddique, ...
Blood, The Journal of the American Society of Hematology 116 (11), 1908-1918, 2010
Mutation Status of the Residual ATM Allele Is an Important Determinant of the Cellular Response to Chemotherapy and Survival in Patients With Chronic …
B Austen, A Skowronska, C Baker, JE Powell, A Gardiner, D Oscier, ...
Journal of Clinical Oncology 25 (34), 5448-5457, 2007
Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL
B Austen, JE Powell, A Alvi, I Edwards, L Hooper, J Starczynski, ...
Blood 106 (9), 3175-3182, 2005
p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative toTP53 mutation
AR Pettitt, PD Sherrington, G Stewart, JC Cawley, AMR Taylor, ...
Blood, The Journal of the American Society of Hematology 98 (3), 814-822, 2001
The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo
VJ Weston, CE Oldreive, A Skowronska, DG Oscier, G Pratt, MJS Dyer, ...
Blood, The Journal of the American Society of Hematology 116 (22), 4578-4587, 2010
Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers
C Pepper, TT Lin, G Pratt, S Hewamana, P Brennan, L Hiller, R Hills, ...
Blood, The Journal of the American Society of Hematology 112 (9), 3807-3817, 2008
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
F Nadeu, J Delgado, C Royo, T Baumann, T Stankovic, M Pinyol, P Jares, ...
Blood, The Journal of the American Society of Hematology 127 (17), 2122-2130, 2016
PFI-1, a highly selective protein interaction inhibitor, targeting BET Bromodomains
S Picaud, D Da Costa, A Thanasopoulou, P Filippakopoulos, PV Fish, ...
Cancer research 73 (11), 3336-3346, 2013
CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions
M Zimmermann, O Murina, MAM Reijns, A Agathanggelou, R Challis, ...
Nature 559 (7713), 285-289, 2018
Mutations associated with variant phenotypes in ataxia-telangiectasia.
CM McConville, T Stankovic, PJ Byrd, GM McGuire, QY Yao, GG Lennox, ...
American journal of human genetics 59 (2), 320, 1996
Analysis of the ATM protein in wild-type and ataxia telangiectasia cells.
ND Lakin, P Weber, T Stankovic, ST Rottinghaus, AM Taylor, SP Jackson
Oncogene 13 (12), 2707-2716, 1996
ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells
M Kwok, N Davies, A Agathanggelou, E Smith, C Oldreive, E Petermann, ...
Blood, The Journal of the American Society of Hematology 127 (5), 582-595, 2016
Ataxia telangiectasia mutated–deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired …
T Stankovic, GS Stewart, C Fegan, P Biggs, J Last, PJ Byrd, RD Keenan, ...
Blood, The Journal of the American Society of Hematology 99 (1), 300-309, 2002
RIDDLE immunodeficiency syndrome is linked to defects in 53BP1-mediated DNA damage signaling
GS Stewart, T Stankovic, PJ Byrd, T Wechsler, ES Miller, A Huissoon, ...
Proceedings of the National Academy of Sciences 104 (43), 16910-16915, 2007
A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and …
AJ Alvi, B Austen, VJ Weston, C Fegan, D MacCallum, ...
Blood 105 (11), 4484-4491, 2005
Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial
A Skowronska, A Parker, G Ahmed, C Oldreive, Z Davis, S Richards, ...
Journal of Clinical Oncology 30 (36), 4524-4532, 2012
The system can't perform the operation now. Try again later.
Articles 1–20